RA Capital Management - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 86 filers reported holding RELMADA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 2.25 and the average weighting 0.0%.

Quarter-by-quarter ownership
RA Capital Management ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$74,040,000
+94.9%
2,000,0000.0%1.58%
+56.0%
Q2 2022$37,980,000
-29.6%
2,000,0000.0%1.01%
-14.0%
Q1 2022$53,980,000
+19.8%
2,000,0000.0%1.18%
+48.4%
Q4 2021$45,060,000
+53.3%
2,000,000
+156.0%
0.79%
+47.6%
Q3 2020$29,392,000
-22.9%
781,290
-8.3%
0.54%
-27.6%
Q2 2020$38,123,000
-19.0%
851,907
-38.3%
0.74%
-50.0%
Q1 2020$47,071,000
+58.5%
1,379,988
+81.2%
1.49%
+65.0%
Q4 2019$29,705,000761,6660.90%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Guild Investment Management, Inc. 205,300$615,9001.03%
Deep Track Capital, LP 2,837,818$8,513,4540.33%
PARSONS CAPITAL MANAGEMENT INC/RI 974,082$2,922,2460.23%
apricus wealth, LLC 77,362$239,8220.21%
Palo Alto Investors LP 732,400$2,197,2000.21%
RTW INVESTMENTS, LP 2,131,835$6,395,5050.14%
SILVERARC CAPITAL MANAGEMENT, LLC 100,000$300,0000.09%
AdvisorShares Investments LLC 112,908$338,7240.09%
Savior LLC 3,500$10,5000.07%
Spotlight Asset Group, Inc. 20,000$60,0000.05%
View complete list of RELMADA THERAPEUTICS INC shareholders